Suppression of Matrix Metalloproteinase Production in Nasal Fibroblasts by Tranilast, an Antiallergic Agent, In Vitro

Allergic rhinitis is an inflammatory disease characterized by nasal wall remodeling with intense infiltration of eosinophils and mast cells/basophils. Matrix metalloproteinases (MMPs), MMP-2 and MMP-9, are the major proteolytic enzymes that induce airway remodeling. These enzymes are also important...

Full description

Saved in:
Bibliographic Details
Main Authors: Toshiyuki Shimizu, Kenichi Kanai, Kazuhito Asano, Tadashi Hisamitsu, Harumi Suzaki
Format: Article
Language:English
Published: Wiley 2005-01-01
Series:Mediators of Inflammation
Online Access:http://dx.doi.org/10.1155/MI.2005.150
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832551358319820800
author Toshiyuki Shimizu
Kenichi Kanai
Kazuhito Asano
Tadashi Hisamitsu
Harumi Suzaki
author_facet Toshiyuki Shimizu
Kenichi Kanai
Kazuhito Asano
Tadashi Hisamitsu
Harumi Suzaki
author_sort Toshiyuki Shimizu
collection DOAJ
description Allergic rhinitis is an inflammatory disease characterized by nasal wall remodeling with intense infiltration of eosinophils and mast cells/basophils. Matrix metalloproteinases (MMPs), MMP-2 and MMP-9, are the major proteolytic enzymes that induce airway remodeling. These enzymes are also important in the migration of inflammatory cells through basement membrane components. We evaluated whether tranilast (TR) could inhibit MMP production from nasal fibroblasts in response to tumor necrosis factor-α (TNF-α) stimulation in vitro. Nasal fibroblasts (NF) were established from nasal polyp tissues taken from patients with allergic rhinitis. NF (2×105 cells/mL) were stimulated with TNF-α in the presence of various concentrations of TR. After 24 hours, the culture supernatants were obtained and assayed for MMP-2, MMP-9, TIMP-1, and TIMP-2 levels by ELISA. The influence of TR on mRNA expression of MMPs and TIMPs in cells cultured for 12 hours was also evaluated by RT-PCR. TR at more than 5×10−5 M inhibited the production of MMP-2 and MMP-9 from NF in response to TNF-α stimulation, whereas TIMP-1 and TIMP-2 production was scarcely affected. TR also inhibited MMP mRNA expression in NF after TNF-α stimulation. The present data suggest that the attenuating effect of TR on MMP-2 and MMP-9 production from NF induced by inflammatory stimulation may underlie the therapeutic mode of action of the agent in patients with allergic diseases, including allergic rhinitis.
format Article
id doaj-art-8e6fdff645844c5c8d560ad0f37adb97
institution Kabale University
issn 0962-9351
1466-1861
language English
publishDate 2005-01-01
publisher Wiley
record_format Article
series Mediators of Inflammation
spelling doaj-art-8e6fdff645844c5c8d560ad0f37adb972025-02-03T06:01:39ZengWileyMediators of Inflammation0962-93511466-18612005-01-012005315015910.1155/MI.2005.150Suppression of Matrix Metalloproteinase Production in Nasal Fibroblasts by Tranilast, an Antiallergic Agent, In VitroToshiyuki Shimizu0Kenichi Kanai1Kazuhito Asano2Tadashi Hisamitsu3Harumi Suzaki4Department of Otolaryngology, School of Medicine, Showa University, Tokyo 142-8666, JapanDepartment of Otolaryngology, School of Medicine, Showa University, Tokyo 142-8666, JapanDepartment of Physiology, School of Medicine, Showa University, Tokyo 142-8555, JapanDepartment of Physiology, School of Medicine, Showa University, Tokyo 142-8555, JapanDepartment of Otolaryngology, School of Medicine, Showa University, Tokyo 142-8666, JapanAllergic rhinitis is an inflammatory disease characterized by nasal wall remodeling with intense infiltration of eosinophils and mast cells/basophils. Matrix metalloproteinases (MMPs), MMP-2 and MMP-9, are the major proteolytic enzymes that induce airway remodeling. These enzymes are also important in the migration of inflammatory cells through basement membrane components. We evaluated whether tranilast (TR) could inhibit MMP production from nasal fibroblasts in response to tumor necrosis factor-α (TNF-α) stimulation in vitro. Nasal fibroblasts (NF) were established from nasal polyp tissues taken from patients with allergic rhinitis. NF (2×105 cells/mL) were stimulated with TNF-α in the presence of various concentrations of TR. After 24 hours, the culture supernatants were obtained and assayed for MMP-2, MMP-9, TIMP-1, and TIMP-2 levels by ELISA. The influence of TR on mRNA expression of MMPs and TIMPs in cells cultured for 12 hours was also evaluated by RT-PCR. TR at more than 5×10−5 M inhibited the production of MMP-2 and MMP-9 from NF in response to TNF-α stimulation, whereas TIMP-1 and TIMP-2 production was scarcely affected. TR also inhibited MMP mRNA expression in NF after TNF-α stimulation. The present data suggest that the attenuating effect of TR on MMP-2 and MMP-9 production from NF induced by inflammatory stimulation may underlie the therapeutic mode of action of the agent in patients with allergic diseases, including allergic rhinitis.http://dx.doi.org/10.1155/MI.2005.150
spellingShingle Toshiyuki Shimizu
Kenichi Kanai
Kazuhito Asano
Tadashi Hisamitsu
Harumi Suzaki
Suppression of Matrix Metalloproteinase Production in Nasal Fibroblasts by Tranilast, an Antiallergic Agent, In Vitro
Mediators of Inflammation
title Suppression of Matrix Metalloproteinase Production in Nasal Fibroblasts by Tranilast, an Antiallergic Agent, In Vitro
title_full Suppression of Matrix Metalloproteinase Production in Nasal Fibroblasts by Tranilast, an Antiallergic Agent, In Vitro
title_fullStr Suppression of Matrix Metalloproteinase Production in Nasal Fibroblasts by Tranilast, an Antiallergic Agent, In Vitro
title_full_unstemmed Suppression of Matrix Metalloproteinase Production in Nasal Fibroblasts by Tranilast, an Antiallergic Agent, In Vitro
title_short Suppression of Matrix Metalloproteinase Production in Nasal Fibroblasts by Tranilast, an Antiallergic Agent, In Vitro
title_sort suppression of matrix metalloproteinase production in nasal fibroblasts by tranilast an antiallergic agent in vitro
url http://dx.doi.org/10.1155/MI.2005.150
work_keys_str_mv AT toshiyukishimizu suppressionofmatrixmetalloproteinaseproductioninnasalfibroblastsbytranilastanantiallergicagentinvitro
AT kenichikanai suppressionofmatrixmetalloproteinaseproductioninnasalfibroblastsbytranilastanantiallergicagentinvitro
AT kazuhitoasano suppressionofmatrixmetalloproteinaseproductioninnasalfibroblastsbytranilastanantiallergicagentinvitro
AT tadashihisamitsu suppressionofmatrixmetalloproteinaseproductioninnasalfibroblastsbytranilastanantiallergicagentinvitro
AT harumisuzaki suppressionofmatrixmetalloproteinaseproductioninnasalfibroblastsbytranilastanantiallergicagentinvitro